Trusted Resource for Clinical Trials, Protocols & Progress
Retrospective chart reviews typically involve large databases, such as electronic health records (EHRs) or archived paper files. Reviewing every case is often impractical and unnecessary. Instead, a representative sample provides sufficient statistical power while reducing cost and workload. A well-planned sampling strategy:
Click to read the full article.
Unlike prospective trials where data collection is planned and monitored, retrospective studies depend on existing records not designed for research. As a result, data may be:
Click to read the full article.
Retrospective data often comes from diverse healthcare settings with inconsistent documentation formats. Diagnosis coding helps convert free-text or variably structured clinical entries into consistent, analyzable data. Benefits include:
Click to read the full article.
HIPAA governs how protected health information (PHI) is accessed, stored, and disclosed. Violations can result in significant penalties, reputational damage, and legal consequences. In chart reviews—often involving sensitive electronic health records (EHRs)—ensuring data privacy is essential to:
Click to read the full article.
Electronic Medical Records (EMRs) are digital versions of patient charts maintained in healthcare IT systems. Paper charts are physical files with handwritten or printed clinical documentation. The choice between them affects study planning, data quality, and compliance.
Click to read the full article.
Unlike randomized controlled trials (RCTs), retrospective studies are prone to bias, incomplete data, and lack of pre-specified protocols. Standardized reporting:
Click to read the full article.
Every successful cohort study begins with a clear objective. Define what you want to assess—this could be the incidence of a particular event (e.g., cardiovascular outcome), progression of a condition (e.g., chronic kidney disease), or the comparative effectiveness of a treatment in real-world settings.
Click to read the full article.
A comparison group—also referred to as a control group or unexposed group—is essential for assessing the effect of an exposure (e.g., drug, intervention, or risk factor). It provides a reference to determine whether observed outcomes are associated with the exposure or occur independently. Without a properly matched comparison group, confounding variables may distort the results, weakening the conclusions.
Click to read the full article.
Longitudinal data allows researchers to monitor disease progression, drug effectiveness, and safety profiles across various time intervals. These data are essential for:
Click to read the full article.
LTFU occurs when participants enrolled in a study fail to complete scheduled follow-up assessments. This can result in missing outcome data, reduced statistical power, and biased estimates—especially if dropout is related to exposure or outcome.
Click to read the full article.
